miRNA Expression Profiling in Melanocytes and Melanoma Cell Lines Reveals miRNAs Associated with Formation and Progression of Malignant Melanoma

被引:206
作者
Mueller, Daniel W. [1 ]
Rehli, Michael [2 ]
Bosserhoff, Anja K. [1 ]
机构
[1] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany
[2] Univ Hosp Regensburg, Inst Haematol & Internal Oncol, Regensburg, Germany
关键词
INHIBITORY-ACTIVITY; MESSENGER-RNAS; IN-VITRO; FUNCTIONAL-ROLE; HUMAN CANCERS; UP-REGULATION; SOLID TUMORS; MICRORNAS; MIA; METASTASIS;
D O I
10.1038/jid.2008.452
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Although deregulated expression of microRNAs (miRNAs) demonstrably contributes to the development and progression of all types of human cancers, little data are available about the changes in miRNA expression levels in malignant melanoma. In our study, we performed microarray-based miRNA profiling of melanocytes and melanoma cell lines derived from either primary tumors or metastatic melanomas. In addition, we analyzed miRNA expression patterns of melanoma cell clones in which the expression of melanoma specific genes was stably knocked down by antisense techniques. We also generated miRNA expression profiles for two derivatives of a melanoma cell line that differ in their invasive potential. Comparing miRNA expression patterns of melanocytes and subsets of melanoma cell lines, we identified large cohorts of miRNAs associated with malignant transformation as well as with the progression of the disease and with metastatic colonization. Surprisingly, the bulk of miRNAs that deregulated most strongly was not described to be of importance in tumor development before. The results of our study, therefore, not only provide insights into alterations in the miRnomes of melanocytes and melanoma cell lines during melanoma progression but also present a large assortment of miRNAs to be analyzed for their potential as diagnostic markers or targets for therapies in the future.
引用
收藏
页码:1740 / 1751
页数:12
相关论文
共 58 条
[1]   Regulation of integrin activity by MIA [J].
Bauer, R ;
Humphries, M ;
Fässler, R ;
Winklmeier, A ;
Craig, SE ;
Bosserhoff, AK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (17) :11669-11677
[2]   MRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes [J].
Behm-Ansmant, Isabelle ;
Rehwinkel, Jan ;
Doerks, Tobias ;
Stark, Alexander ;
Bork, Peer ;
Izaurralde, Elisa .
GENES & DEVELOPMENT, 2006, 20 (14) :1885-1898
[3]   RBP1 family proteins exhibit SUMOylation-dependent transcriptional repression and induce cell growth inhibition reminiscent of senescence [J].
Binda, O ;
Roy, JS ;
Branton, PE .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (05) :1917-1931
[4]   Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity [J].
Bosserhoff, AK ;
Stoll, R ;
Sleeman, JP ;
Bataille, F ;
Buettner, R ;
Holak, TA .
LABORATORY INVESTIGATION, 2003, 83 (11) :1583-1594
[5]   Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo [J].
Bosserhoff, AK ;
Echtenacher, B ;
Hein, R ;
Buettner, R .
MELANOMA RESEARCH, 2001, 11 (04) :417-421
[6]   Principles of MicroRNA-target recognition [J].
Brennecke, J ;
Stark, A ;
Russell, RB ;
Cohen, SM .
PLOS BIOLOGY, 2005, 3 (03) :404-418
[7]   Identification of metastasis-related microRNAs in hepatocellular carcinoma [J].
Budhu, Anuradha ;
Jia, Hu-Liang ;
Forgues, Marshonna ;
Liu, Chang-Gong ;
Goldsteir, David ;
Lam, Amy ;
Zanetti, Krista A. ;
Ye, Qing-Hai ;
Qin, Lun-Yju ;
Croce, Carlo M. ;
Tang, Zhao-You ;
Wang, Xin Wei .
HEPATOLOGY, 2008, 47 (03) :897-907
[8]   MicroRNA functions [J].
Bushati, Natascha ;
Cohen, Stephen M. .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2007, 23 :175-205
[9]   Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs [J].
Cai, XZ ;
Hagedorn, CH ;
Cullen, BR .
RNA, 2004, 10 (12) :1957-1966
[10]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866